DrugPatentWatch Database Preview
Par Form Company Profile
» See Plans and Pricing
What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?
PAR FORM has five approved drugs.
There is one tentative approval on PAR FORM drugs.
Summary for Par Form
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Par Form
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-002 | Jul 10, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Par Form | DICLOFENAC POTASSIUM | diclofenac potassium | FOR SOLUTION;ORAL | 202964-001 | May 2, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Par Form | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 203836-002 | Aug 19, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Par Form | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 203836-001 | Aug 19, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-001 | Jul 10, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
